Pregnant

Ohio-based Cleveland Clinic has revealed plans to conduct the first-ever clinical uterus transplant trial in the US.

In September, the clinic began screening candidates, aged 21 to 39, who suffer from uterine factor infertility (UFI).

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

UFI is a condition in women who cannot become pregnant because they were born without, have lost, or have a uterus that no longer functions.

A research study has been launched with the first transplant expected to take place in the next few months. The clinic will perform uterus transplants in ten women with UFI.

Cleveland Clinic Dr Tommaso Falcone said: "Although there appears to be potential for treating UFI with uterine transplantation, it is still considered highly experimental.

"Cleveland Clinic has a history of innovation in transplant and reproductive surgery and will explore the feasibility of this approach for women in the US."

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Each candidate approved for the study will follow a protocol that involves stimulating ovaries to produce multiple eggs. These eggs will be retrieved, fertilised in a laboratory, and frozen.

Selected by organ procurement agency Lifebanc, a donor uterus will be transplanted within six to eight hours into the patient’s pelvis.

"Although there appears to be potential for treating UFI with uterine transplantation, it is still considered highly experimental."

After a year-long healing period, the frozen embryos will be implanted into the patient until she becomes pregnant.

The baby is delivered by caesarean section. After one or two babies have been delivered, hysterectomy will be performed on the patient to remove the transplanted uterus.

Cleveland Clinic lead investigator Andreas Tzakis said: "Unlike any other transplants, they are ‘ephemeral’.

"They are not intended to last for the duration of the recipient’s life, but will be maintained for only as long as is necessary to produce one or two children."

Last month, the UK’s Health Research Authority gave approval for womb transplants in a clinical trial by London’s Imperial College Healthcare.

In 2014, the world’s first successful uterus transplant birth occurred in Sweden.


Image: Pregnant woman at a WIC clinic in Virginia, US. Photo: courtesy of Ken Hammond (USDA).

Clinical Trials Arena Excellence Awards - Nominations Closed

Nominations are now closed for the Clinical Trials Arena Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
Science 37 has won the Research and Development Award in the Site Innovation category for its FDA inspected Direct-to-Patient Site model, delivering nationwide access, faster enrollment and higher retention. Explore how its virtual-first, in home approach is reshaping trial operations and accelerating time to data-driven decisions..

Discover the Impact